Analyst Consensus
- Current Price
- 123.86 $
- Target (Low)
- 131.00 $
- Target (Mean)
- 137.83 $
- Target (High)
- 146.00 $
- Recommendation
- Buy
- Number of Analysts
- 18
Recommendation Distribution
Recommendation Distribution| Strong Buy | 3 |
|---|
| Buy | 8 |
|---|
| Hold | 12 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 15.7%
- Operating Margin
- 25.5%
- Gross Margin
- 51.1%
- Return on Equity (ROE)
- 9.7%
- Return on Assets (ROA)
- 2.8%
- Revenue Growth
- 11.3%
- Earnings Growth
- 12.0%
- Debt/Equity
- 161.50
- Current Ratio
- 0.66
- Beta
- 0.38
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 18, 2026 | Barclays | Overweight → Overweight |
| Jun 18, 2026 | Mizuho | Outperform → Outperform |
| May 18, 2026 | Truist Securities | Buy → Buy |
| May 13, 2026 | JP Morgan | Neutral → Neutral |
| May 6, 2026 | Mizuho | Outperform → Outperform |
| Apr 21, 2026 | Morgan Stanley | Equal-Weight → Equal-Weight |